Stockscreener 앱 받기
7.86
5.79%
0.43
시간 외 거래:
7.86
전일 마감가:
$7.43
열려 있는:
$8.03
하루 거래량:
148.22K
Relative Volume:
1.85
시가총액:
$453.38M
수익:
$154.57M
순이익/손실:
$15.07M
주가수익비율:
29.11
EPS:
0.27
순현금흐름:
$10.92M
1주 성능:
+11.33%
1개월 성능:
+11.02%
6개월 성능:
+1.95%
1년 성능:
+15.59%
1일 변동 폭
$7.56
$8.045
1주일 범위
$6.92
$8.045
52주 변동 폭
$5.54
$9.155
Kamada Ltd Stock (KMDA) Company Profile
KMDA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
7.86 | 428.57M | 154.57M | 15.07M | 10.92M | 0.27 |
|
ZTS
Zoetis Inc
|
125.67 | 57.00B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.90 | 49.88B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.05 | 45.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.40 | 36.84B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
52.88 | 16.33B | 0 | -5.87M | -767.30K | -0.45 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 개시 | The Benchmark Company | Buy |
| 2024-07-03 | 개시 | Stifel | Buy |
| 2018-02-02 | 개시 | Chardan Capital Markets | Buy |
Kamada Ltd 주식(KMDA)의 최신 뉴스
Kamada (KMDA) Projects Strong Revenue and EBITDA Growth by 2026 - GuruFocus
Kamada shares climb after upbeat 2026 outlook points to double-digit growth - MSN
Kamada stock rises after issuing 2026 guidance showing double-digit growth - Investing.com Canada
Kamada forecasts 13% revenue growth in 2026, issues guidance By Investing.com - Investing.com Nigeria
Kamada Provides 2026 Annual Guidance of $200$205 Million - GlobeNewswire
Kamada (NASDAQ:KMDA) Stock Crosses Above 50 Day Moving AverageHere's Why - MarketBeat
Leasing LimitedFundamental Strength Indicators & Free Exceptional ROI Methods - bollywoodhelpline.com
Kamada Ltd. (NASDAQ:KMDA) Short Interest Update - MarketBeat
Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving AverageTime to Sell? - MarketBeat
Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving Average – Time to Sell? - Defense World
Kamada (KMDA) price target decreased by 11.86% to 13.26 - MSN
Kamada (KMDA) Stock Analysis Report | Financials & Insights - Benzinga
Kamada Ltd.(NasdaqGS: KMDA) added to NASDAQ Biotechnology Index - marketscreener.com
Is Kamada Ltd. stock affected by interest rate hikesInsider Selling & Long-Term Growth Plans - Улправда
Will Kamada Ltd. stock see insider buyingWeekly Trend Recap & Precise Entry and Exit Recommendations - Улправда
Is Kamada Ltd. stock positioned well for digital economyLayoff News & Fast Exit and Entry Strategy Plans - Улправда
Can Kamada Ltd. stock resist sector downturns2025 Top Gainers & Expert-Curated Trade Recommendations - DonanımHaber
Kamada announces $10M-$14M extension of Canadian supply tender - TipRanks
Can Kamada Ltd. stock rebound after recent weaknessIndex Update & Consistent Return Strategy Ideas - Улправда
Breakout Watch: Is Kamada Ltd. stock positioned well for digital economyJuly 2025 News Drivers & Growth Focused Entry Point Reports - Улправда
Kamada secures $10-14 million Canadian supply tender extension By Investing.com - Investing.com Nigeria
Kamada Ltd. Announces $10 Million to $14 Million Extension of Canadian Supply Tender - marketscreener.com
Kamada Receives Two-Year Supply Extension From Canadian Blood Services for Plasma-Derived Products - marketscreener.com
Kamada Wins $10–$14 Million Extension of Canadian Plasma-Product Tender - TipRanks
Kamada secures $10-14 million Canadian supply tender extension - Investing.com
Kamada (KMDA) announces $10–$14 million extension of Canadian tender - Stock Titan
Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender - GlobeNewswire
Kamada Initiates Clinical Trial for CYTOGAM in Kidney Transplantation - MSN
Kamada shares drop as company halts Phase 3 study of inhaled AAT therapy - MSN
Breakout Zone: How geopolitical tensions affect Kamada Ltd stock2025 Earnings Surprises & Consistent Return Investment Signals - moha.gov.vn
Precision Trading with Kamada Ltd. (KMDA) Risk Zones - Stock Traders Daily
Kamada (NASDAQ:KMDA) Stock Rating Upgraded by Wall Street Zen - Defense World
FY2025 Earnings Forecast for Kamada Issued By HC Wainwright - Defense World
What is HC Wainwright's Forecast for Kamada FY2025 Earnings? - MarketBeat
Sidoti Csr Comments on Kamada’s Q1 Earnings (NASDAQ:KMDA) - Defense World
HC Wainwright Has Bearish Outlook for Kamada FY2026 Earnings - Defense World
Kamada Ltd. Shareholders Approve Key Resolutions at Annual Meeting - TipRanks
Sidoti Csr Predicts Kamada's Q1 Earnings (NASDAQ:KMDA) - MarketBeat
H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus - Investing.com Nigeria
H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus By Investing.com - Investing.com South Africa
Why Is Kamada Stock Trading lower todayKamada (NASDAQ:KMDA) - Benzinga
Kamada to Discontinue Phase 3 Trial of Inhaled AAT: Shares Fall - marketscreener.com
Kamada discontinues Phase 3 inhaled AAT clinical trial - TipRanks
Kamada reiterates FY25 revenue guidance $178M-$182M - TipRanks
Kamada Discontinues Phase 3 Inhaled AAT Trial, Projects Growth in 2026 - TipRanks
Kamada (KMDA) Halts Phase 3 Trial of Inhaled AAT for Alpha-1 Ant - GuruFocus
Kamada reiterates 2025 FY revenue guidance of $178M-$182M - marketscreener.com
Kamada Reiterates 2025 FY Revenue Guidance Of $178M-$182M - TradingView
Kamada stock tumbles after discontinuing Phase 3 Inhaled AAT trial By Investing.com - Investing.com Canada
Kamada Ltd (KMDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.03%
2.38%
자본화:
|
볼륨(24시간):